0.6690USD-0.39%Mkt Cap: 262.64M $P/E: —2d ago
Standard BioTools Inc., together with its subsidiaries, develops, manufactures, and sells a range of instrumentation, consumables, and services to scientists and biomedical researchers to develop therapeutics in the Amer…
Industry Peers
Medical Devices$203.17BUSDP/E 37.7
$126.37BUSDP/E 34.2
$119.49BUSDP/E 25.0
$73.00BUSDP/E 20.4
$48.43BUSDP/E 19.9
$51.70BUSDP/E 53.4
$34.85BUSDP/E 36.5
$34.04BUSDP/E 17.2
$25.08BUSDP/E 20.7
$26.80BUSDP/E 20.8
$23.20BUSDP/E 29.1
$19.26BUSDP/E 24.5
$12.81BUSDP/E 79.7
$12.25BUSDP/E 19.9
$11.48BUSDP/E 19.8
$11.67BUSDP/E 22.2
$10.91BUSD
$10.01BUSDP/E 17.1
$10.28BUSDP/E 27.5
$10.17BUSDP/E 46.3
| Headline | Source | Time |
|---|---|---|
Older | ||
Standard BioTools Sells Mass Cytometry Business Amid Pending Merger With Treeline Biosciences Standard BioTools (LAB) said Tuesday that it has agreed to sell its Mass Cytometry business to Multi | MMT Newswires | |